Salicylism from Salicylic Acid Peels: Concentration, Quantity, Body Surface Area, and Time

What is Salicylism?

• Tinnitus (most characteristic early sign)
• Headache and dizziness
• Nausea, vomiting
• Hyperventilation / dyspnea (medullary respiratory center stimulation)
• Mental confusion, delirium, psychosis
• Drowsiness, stupor, and in severe cases - coma and death

Concentrations Used in Chemical Peels

When Does Topical Salicylism Occur?

• 6% salicylic acid applied over 40% or more of body surface area (BSA) can cause salicylism - this is the lowest documented threshold from case reports.

• Applying lotion to 70% BSA (most of arms, legs, trunk) = approximately 16 g of product per single application
• If that product contains 6% SA → ~1 g of salicylic acid applied
• With ~60% dermal absorption → maximum plasma level ~0.6 g
• This level is still well below the toxicity threshold for a single application in a healthy adult with intact skin
• However, in adults: 1 g of topically applied 6% SA raises serum salicylate by no more than 0.5 mg/dL - threshold for toxicity is 30-50 mg/dL (Katzung, 16th ed.)

1. Repeated frequent application (e.g., 3-6 times per day) over days
2. Large BSA (>40-60%)
3. Compromised skin barrier (psoriasis, ichthyosis, erythroderma)
4. Higher concentrations (e.g., 20.7% twice daily over 50% BSA - this caused coma and death)

Documented Case Data (from peer-reviewed review, JAAD 2014)

30% Peel Specifically - Safety Data

• Mean plasma SA level: 0.81 µg/mL after application
• Toxic plasma threshold: 300 µg/mL
• Margin of safety (MOS): 370x for toxicity, 432x for salicylism threshold
• This makes standard 30% SA chemical peels on limited facial/body areas very safe with intact skin

Key Risk Factors That Lower the Threshold for Salicylism

1. Broken/inflamed skin (psoriasis, ichthyosis, eczema) - absorption increases dramatically
2. Children - higher surface-area-to-body-mass ratio → higher serum levels per gram absorbed
3. Renal or hepatic impairment - impaired elimination
4. Large BSA treatment - >40% BSA is a significant risk zone
5. Prolonged or frequent repeated application over days
6. Occlusion (wrapping after application) - massively increases absorption
7. Concurrent salicylate use (aspirin, NSAIDs)

Practical Safety Guidelines for Body Chemical Peels

• Limit total SA applied; avoid treating >40% BSA in a single session with concentrations ≥6%
• For body peeling, apply in sections/stages rather than all at once
• Never occlude after application unless specifically indicated and carefully monitored
• Use with extreme caution (or avoid) in patients with ichthyosis, psoriasis, or broken skin over large areas
• Avoid in children, pregnancy, and patients with renal/hepatic disease
• Monitor for early salicylism signs: tinnitus is the key early warning

• Katzung's Basic and Clinical Pharmacology, 16th ed. - topical salicylic acid section
• Goodman & Gilman's Pharmacological Basis of Therapeutics - salicylate intoxication section
• JAAD 2014 - Review of toxicity from topical salicylic acid - case series and pharmacokinetic estimates
• PMC review: Salicylic acid as a peeling agent - concentrations, formulations, salicylism risk

Treatment of Salicylism

Step 1 - Immediate: Remove the Source

• Stop all topical salicylic acid application immediately
• For oral overdose: decontamination if within 1 hour of ingestion
• Wash skin thoroughly if topical exposure is ongoing

Step 2 - Decontamination (Oral Ingestion Only)

• Effective if given within 1 hour of ingestion
• Large ingestions form gastric concretions, so multiple doses of AC may be indicated
• AC is not used in chronic/topical salicylism - presentation occurs long after GI absorption has completed
• Do NOT give sodium bicarbonate orally - it increases GI absorption of salicylate

Step 3 - Supportive Care

Critical note on intubation: If mechanical ventilation is required, set respiratory rate high to match the patient's pre-intubation hyperventilation. Normalizing the rate will cause rapid accumulation of CO2, worsening acidosis and driving salicylate into the CNS - this can be fatal.

Step 4 - Enhanced Elimination: Urinary Alkalinization

• Initial bolus: 1 mEq/kg IV NaHCO₃
• Maintenance infusion: 3 ampules of NaHCO₃ (each 44-50 mEq) added to 1 L of D5W, plus 40 mEq KCl per liter (once urine output confirmed and no hyperkalemia)
• Alternatively: 1 L D5W + 3 × 50 mL ampules of 8.4% NaHCO₃ (132-150 mEq total) + 30-40 mEq KCl
• Infusion rate: Titrate to urine output of 2-3 mL/kg/hr
• Target urine pH: >7.5
• Check urine pH frequently
• Continue until serum salicylate falls to <30 mg/dL

• Do not use acetazolamide - although it alkalinizes urine, it causes systemic metabolic acidosis, which worsens CNS toxicity
• Hypokalemia must be corrected - the kidney will preferentially reabsorb K+ over Na+ in hypokalemia, making urinary alkalinization impossible
• Sodium bicarbonate may be difficult or dangerous in CHF, cerebral edema, or pulmonary edema

Step 5 - Hemodialysis

Urinary alkalinization should be started while preparing for hemodialysis and continued during the procedure.

Step 6 - Monitoring

• Serial serum salicylate levels every 2-4 hours until clearly trending down
• Arterial blood gas (ABG) - monitor pH and acid-base status
• Serum electrolytes, glucose, renal function
• Urine pH with each void
• A rebound in serum salicylate can occur after stopping bicarbonate infusion (reported in ~2% of cases) - usually mild

Summary Algorithm

Salicylism confirmed
        ↓
Stop source → Supportive care (fluids, glucose, K+, temperature)
        ↓
Oral ingestion <1 hr? → Activated charcoal (multiple doses if large ingestion)
        ↓
Level >30 mg/dL or symptomatic? → IV NaHCO₃ infusion (urinary alkalinization)
        ↓
Level ≥100 mg/dL (acute) / ≥40-60 mg/dL (chronic) / CNS symptoms / AKI / ALI?
        ↓
         → HEMODIALYSIS (+ continue urine alkalinization)

• Rosen's Emergency Medicine, 9th ed. - salicylate poisoning chapter
• Morgan & Mikhail's Clinical Anesthesiology - metabolic acidosis and salicylate alkalinization
• ACMT Guidance: Management Priorities in Salicylate Toxicity
• Medscape: Salicylate Toxicity Treatment
• PMC - Sodium Bicarbonate in Toxic Ingestions